(Reuters) - The U.S. Food and Drug Administration (FDA) on Friday expanded the use of Novartis AG's relapsing multiple sclerosis (MS) drug Gilenya to treat children and adolescents.
from Reuters: Health News https://ift.tt/2rBQHeo
from Reuters: Health News https://ift.tt/2rBQHeo
FDA expands use of Novartis MS drug to pediatric patients
![FDA expands use of Novartis MS drug to pediatric patients]()
Reviewed by sajjad
on
May 14, 2018
Rating:
No comments: